Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

EGFR mutation status in Tunisian non-small-cell lung cancer patients evaluated by mutation-specific immunohistochemistry.

BMC pulmonary medicine - 9 Aug 2018

Mraihi Zohra, Ben Amar Jihen, Bouacha Hend, Rammeh Soumaya, Hila Lamia

Abstract excerpt

BACKGROUND: Screening mutations in epidermal growth factor receptor (EGFR) to analyze non-small-cell lung cancer (NSCLC) profile is the criterion to choose the best therapeutic strategy. New Oncology guidelines recommend EGFR mutation analysis before prescribing tyrosine kinase inhibitors (TKIs) treatment. Majority of lung cancer patients are diagnosed at advanced stages and generally only small biopsies...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Immunohistochemistry

Share to Lung Neoplasms

Share to Protein Kinase Inhibitors

Share to Tunisia

Source

Open in PubMed Open full text

Identifiers

PMID: 30092812
DOI: 10.1186/s12890-018-0706-5
PMCID: PMC6085720

Genes

EGFR
TTF1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

EGFR mutation status in Tunisian non-small-cell lung cancer patients evaluated by mutation-specific immunohistochemistry.PMID 30092812Read ↗

Assessment of EGFR mutation status in Tunisian patients with pulmonary adenocarcinoma.Semantic proximity Read ↗

Predominance of the Rare EGFR Mutation p.L861Q in Tunisian Patients with Non-Small Cell Lung Carcinoma.Semantic proximity Read ↗

EGFR mutation spectrum and clinical correlations in Tunisian Non-Small cell lung cancer patients.Semantic proximity Read ↗

Clinicopathological and prognostic implications of EGFR mutations subtypes in Moroccan non-small cell lung cancer patients: A first report.Semantic proximity Read ↗

About molecular profile of lung cancer in Tunisian patients.Semantic proximity Read ↗

The prevalence and clinical significance of EGFR mutations in non-small cell lung cancer patients in Egypt: a screening study.Semantic proximity Read ↗

EGFR mutation status in Middle Eastern patients with non-squamous non-small cell lung carcinoma: A single institution experience.Semantic proximity Read ↗

EGFR Mutation in Non-squamous Non-small-cell Lung Carcinoma (NS-NSCLC) in the Arab World: A systematic Review.Semantic proximity Read ↗

Molecular analysis of genetic mutations in non-small cell lung cancer in Morocco.Semantic proximity Read ↗

EGFR MUTATIONS IN NON-SMALL CELL LUNG CANCER: LOCAL EPIDEMIOLOGY AND CLINICAL IMPORTANCE.Semantic proximity Read ↗

EGFR Mutation Detection and Its Association With Clinicopathological Characters of Lung Cancer PatientsSemantic proximity Read ↗

Prevalence of Epidermal Growth Factor Receptor Mutations in Patients with Non-Small Cell Lung Cancer in Turkish Population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.